Everforth Inc quarterly report, Q2 FY2007

Business Context and Reporting Period

Company: On Assignment, Inc. (Note: Input metadata listed "Everforth Inc," but the filing text identifies the registrant as On Assignment, Inc.)
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: June 30, 2007
Business Overview: A diversified professional staffing firm operating in four segments: Life Sciences, Healthcare, Physician, and IT and Engineering. The reporting period was defined by the integration of two major acquisitions: VISTA Staffing Solutions (Physician segment) acquired January 3, 2007, and Oxford Global Resources (IT and Engineering segment) acquired January 31, 2007.

Key Financial Metrics

Metric Six Months Ended
June 30, 2007
Six Months Ended
June 30, 2006
Three Months Ended
June 30, 2007
Three Months Ended
June 30, 2006
Revenues $266,483,000 $135,359,000 $143,854,000 $68,636,000
Gross Profit $83,701,000 $36,252,000 $46,241,000 $19,268,000
Gross Margin 31.4% 26.8% 32.1% 28.1%
Operating Income $10,448,000 $2,822,000 $7,249,000 $2,624,000
Net Income $3,849,000 $2,216,000 $2,938,000 $1,914,000
Diluted EPS $0.11 $0.08 $0.08 $0.07
Cash from Operations $13,846,000 $9,355,000 N/A N/A
Cash & Equivalents (End of Period) $29,383,000 $28,611,000 $29,383,000 $28,611,000
Total Debt (Notes Payable) $144,275,000 $0 $144,275,000 $0
Working Capital $76,681,000 N/A $76,681,000 N/A

Material Changes vs. Prior Period

  • Revenue Growth: Consolidated revenue increased 96.9% year-over-year for the six months ended June 30, 2007. This growth is primarily attributable to the inclusion of VISTA and Oxford revenues post-acquisition, alongside organic growth in Life Sciences (17.2% increase) and Healthcare (8.1% increase) segments.
  • Margin Expansion: Consolidated gross margin improved by 460 basis points to 31.4% for the six-month period. This was driven by the high-margin IT and Engineering segment (37.2%) and improved bill/pay spreads in legacy segments.
  • Debt Financing: The company entered a $165 million senior secured credit facility in January 2007 to finance the Oxford acquisition. This resulted in a significant increase in interest expense ($5.1 million for six months 2007 vs. $3,000 in 2006).
  • Balance Sheet Expansion: Total assets nearly doubled from $187 million to $375 million, driven by $187 million in goodwill and $49 million in identifiable intangible assets recorded from the acquisitions.
  • SG&A Expenses: Selling, general, and administrative expenses increased 119.1% year-over-year, largely due to amortization of acquired intangibles ($7.9 million) and increased headcount.

Guidance, Outlook, Risks, and Unusual Items

  • Outlook: Management expects continued revenue growth in the Physician and IT/Engineering segments due to supply/demand imbalances. They anticipate leveraging SG&A synergies across the new and legacy businesses.
  • Unusual Items:
    • Acquisition Costs: Significant non-cash amortization of intangibles ($7.9 million for six months) and stock-based compensation ($3.3 million) impacted operating income.
    • Swap Gain: A $431,000 gain was recorded on an interest rate swap agreement used to fix rates on $73 million of debt.
    • Tax Provision: The effective tax rate increased to approximately 40% in 2007 following the full reversal of a valuation allowance on deferred tax assets at the end of 2006.
  • Risks and Contingencies:
    • Legal Proceedings: Ongoing litigation (Oxford vs. Black Diamond) regarding non-compete agreements and misappropriation of trade secrets. Discovery is ongoing with a trial anticipated in late January 2008.
    • Contractor Classification: Risk that taxing authorities may reclassify independent contractor physicians as employees, potentially resulting in significant retroactive tax and wage liabilities.
    • Self-Insurance: The company is partially self-insured for workers' compensation and medical malpractice, with a liability of $8.2 million as of June 30, 2007.

Investor Verification Checklist

  • Acquisition Integration: Verify the realization of projected SG&A synergies and the stability of revenue from the newly acquired VISTA and Oxford segments.
  • Debt Covenants: Monitor compliance with the $165 million credit facility covenants, specifically the minimum total leverage ratio and interest coverage ratio.
  • Intangible Asset Amortization: Assess the impact of the $7.9 million amortization expense on future earnings, noting that this is a non-cash charge that will decrease as assets are fully amortized.
  • Legal Exposure: Track the status of the Oxford vs. Black Diamond litigation and potential financial impact of the trial scheduled for early 2008.
  • Contractor Status: Review the company's defense regarding the classification of locum tenens physicians as independent contractors versus employees.
Disclaimer:
This AI-generated summary by MetaQuotes is based on SEC filings and may contain errors. Verify important details against the original SEC filings.